- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.01. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.01.2025 | 461 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 20.01.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.01.2025ISIN NameAU000000CAI2 CALIDUS... ► Artikel lesen | |
| 14.01. | Nasdaq Stockholm AB: Delisting of Ziccum AB from Nasdaq First North Growth Market | 383 | GlobeNewswire | On January 10, 2025, Ziccum AB was declared bankrupt by Lund District Court.
According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the exchange may decide to delist the financial... ► Artikel lesen | |
| 10.01. | XFRA 7IZ: AUSSETZUNG/SUSPENSION | 341 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILZICCUM AB 7IZ SE0011415595... ► Artikel lesen | |
| 10.01. | Ziccum AB: Ziccum AB (publ) files for bankruptcy | 290 | GlobeNewswire (Europe) | The board of directors of Ziccum AB (publ) ("Ziccum"or the "Company") has today, 10 January 2025, resolved to file for bankruptcy on behalf of the Company to manage the financial situation that has... ► Artikel lesen | |
| 25.11.24 | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Ziccum AB (publ) | 344 | GlobeNewswire | With effect from November 26, 2024, the unit rights in Ziccum AB (publ) will be
traded on First North Growth Market. Trading will continue up until and
including December 05, 2024.
Instrument: Unit... ► Artikel lesen | |
| ZICCUM Aktie jetzt für 0€ handeln | |||||
| 20.11.24 | Ziccum AB: Ziccum publishes prospectus due to upcoming rights issue | 276 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 20.11.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.11.2024 | 656 | Xetra Newsboard | Das Instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC ETF wird cum Kapitalmassnahme gehandelt am 20.11.2024 und ex Kapitalmassnahme am 21.11.2024 The instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC... ► Artikel lesen | |
| 29.10.24 | Ziccum AB: Ziccum AB (publ) Interim report Q3 2024 | 163 | GlobeNewswire (Europe) | INTERIM REPORT Q3, 1 JULY - 30 SEPTEMBER 2024
Significant events after Q3 2024Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loanOn October 10, The Board... ► Artikel lesen | |
| 10.10.24 | Ziccum AB: Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loan | 194 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 30.08.24 | Ziccum AB: Ziccum AB (publ) Interim report Q2 2024 | 250 | GlobeNewswire (Europe) | INTERIM REPORT Q2, 1 JANUARY - 30 JUNE 2024
Significant events during Q2 2024Ziccum strengthens and streamlines business and finance functionsOn April 3, the company announced that it is reorganizing... ► Artikel lesen |
10 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,590 | +0,95 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
20.06.2025 /... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,900 | +0,13 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| THERMO FISHER | 349,20 | -0,85 % | Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply | Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 60,80 | -0,52 % | Eurofins Scientific: Eurofins Announces the Success of Its New Schuldschein Issuance of €500m to Refinance its 2025 Schuldschein Loans | Regulatory News:
Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3 by Moody's and BBB- by Fitch), a global leader in bioanalytical testing, announces that it has successfully issued a new €500m... ► Artikel lesen | |
| SYNLAB | 12,900 | +0,70 % | Synlab Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| DAVITA | 119,65 | -0,75 % | 3 Takeaways From DaVita CEO Javier Rodriguez on the Future of Health Technology | NORTHAMPTON, MA / ACCESS Newswire / June 20, 2025 / Health care conversations have outgrown the concept of transformation; what we need now is a revolution, driven by the capabilities of cutting-edge... ► Artikel lesen | |
| DENTSPLY SIRONA | 13,565 | -0,77 % | Dividendenbekanntmachungen (27.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGC INC JP3112000009 105 JPY 0,6216 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1795 EUR ALICO INC US0162301040 0... ► Artikel lesen | |
| SMITH & NEPHEW | 13,030 | +0,08 % | Smith & Nephew UK Ltd: Smith+Nephew's new TRIGEN MAX Tibia Nailing System brings 'next-level nailing' to trauma surgeons repairing tibial fractures | The future of fracture fixation with novel side-specific nails featuring variable angle locking technology
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces... ► Artikel lesen | |
| SONIC HEALTHCARE | 14,822 | +2,00 % | SONIC HEALTHCARE LIMITED: Change in substantial holding | ||
| DIASORIN | 92,40 | -2,12 % | Dividendenbekanntmachungen (21.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AFLAC INC US0010551028 0,58 USD 0,5141 EUR ARCHER DANIELS MIDLAND COMPANY US0394831020 0,51 USD 0,452 EUR ASSECO BUSINESS SOLUTIONS... ► Artikel lesen | |
| PATTERSON COMPANIES | 27,400 | 0,00 % | Patterson Companies Completes Acquisition by Patient Square Capital | Robert Rajalingam Appointed Chief Executive Officer and to Board of Directors
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies ("Patterson" or the "Company"), a leading supplier of products... ► Artikel lesen | |
| FULGENT GENETICS | 16,700 | 0,00 % | Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology | ||
| PERSPECTIVE THERAPEUTICS | 2,940 | -5,16 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Commences Recruitment for [212Pb]VMT-a-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical Trial | [212Pb]VMT-a-NET Phase 1/2a study is advancing into Cohort 3 with a fixed administered dose that is up to 20% higher (6 mCi) than the dose administered to patients in Cohort 2Dosimetry sub-study analysis... ► Artikel lesen | |
| IMPLANTICA | 3,800 | +3,40 % | Implantica submits the last and final module 3 of the FDA PMA Application for RefluxStop for US market approval | VADUZ, Liechtenstein, June 24, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device... ► Artikel lesen | |
| OMNICELL | 25,000 | +0,81 % | Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy and nursing care delivery... ► Artikel lesen |
Das Unternehmen ZICCUM AB kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,001 Euro.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZICCUM AB finden Sie auf Wallstreet Online.